Comments
Loading...

Clover Health Investments

CLOVNASDAQ
Logo brought to you by Benzinga Data
$3.00
-0.09-2.91%
At Close: -
$3.04
0.041.33%
After Hours: 7:59 PM EDT
15 minutes delayed
Consensus Rating1
Market Perform
Highest Price Target1
$3.50
Lowest Price Target1
$1.25
Consensus Price Target1
$2.29

Clover Health Investments (NASDAQ:CLOV) Stock, Analyst Ratings, Price Targets, Forecasts

Clover Health Investments Corp has a consensus price target of $2.29 based on the ratings of 6 analysts. The high is $3.5 issued by Credit Suisse on January 7, 2022. The low is $1.25 issued by Credit Suisse on March 6, 2023. The 3 most-recent analyst ratings were released by Citigroup, Canaccord Genuity, and Credit Suisse on August 11, 2023, March 6, 2023, and March 6, 2023, respectively. With an average price target of $1.92 between Citigroup, Canaccord Genuity, and Credit Suisse, there's an implied -36.95% downside for Clover Health Investments Corp from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
1.2
Strong Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citigroup
Canaccord Genuity
Credit Suisse
SVB Leerink
Cowen & Co.

1calculated from analyst ratings

Analyst Ratings for Clover Health Investments

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Clover Health Investments (CLOV) stock?

A

The latest price target for Clover Health Investments (NASDAQ:CLOV) was reported by Citigroup on August 11, 2023. The analyst firm set a price target for $1.50 expecting CLOV to fall to within 12 months (a possible -50.66% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Clover Health Investments (CLOV)?

A

The latest analyst rating for Clover Health Investments (NASDAQ:CLOV) was provided by Citigroup, and Clover Health Investments maintained their neutral rating.

Q

When was the last upgrade for Clover Health Investments (CLOV)?

A

The last upgrade for Clover Health Investments Corp happened on February 2, 2022 when Cowen & Co. raised their price target to $3. Cowen & Co. previously had an underperform for Clover Health Investments Corp.

Q

When was the last downgrade for Clover Health Investments (CLOV)?

A

The last downgrade for Clover Health Investments Corp happened on January 7, 2022 when Credit Suisse changed their price target from $9 to $3.5 for Clover Health Investments Corp.

Q

When is the next analyst rating going to be posted or updated for Clover Health Investments (CLOV)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clover Health Investments, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clover Health Investments was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

Q

Is the Analyst Rating Clover Health Investments (CLOV) correct?

A

While ratings are subjective and will change, the latest Clover Health Investments (CLOV) rating was a maintained with a price target of $1.00 to $1.50. The current price Clover Health Investments (CLOV) is trading at is $3.04, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch